Vice Minister Huang Guo of the National Drug Administration recently revealed that the agency is leading the modernization of drug regulation through information technology. The administration continues to implement the Smart Drug Regulation Action Plan, focusing on building an integrated system for the registration and approval of drugs, medical devices, and cosmetics. This initiative aims to fulfill the “efficient handling of single transactions” requirement, achieving seamless cooperation throughout the entire process from acceptance and review to approval and certification. As a result, the volume of online acceptance and the rate of timely conclusions have steadily increased, significantly enhancing the quality and efficiency of reviews and approvals.

Currently, all government service matters handled by the National Drug Administration have been transitioned to 100% online processing, and all enterprise-related certificates at the bureau level have been fully digitized. The total number of electronic certificates issued has exceeded 170,000, allowing enterprises to access services through “one network” and “one gateway.”

In response to the rapid growth of online sales for drugs, medical devices, and cosmetics, the National Drug Administration is continuously promoting the establishment of an online sales monitoring platform. By adopting a “network management approach,” the administration strengthens the detection and resolution of issues. Currently, over 27,000 websites are included in daily monitoring, averaging over 10 million product pages monitored each month. This facilitates cross-level collaboration and interaction across various functions such as online monitoring, risk warning, risk identification, verification and resolution, and risk elimination, effectively purifying the online sales environment.

Vice Minister Lei Ping emphasized that the National Drug Administration is reinforcing the construction of information platforms to enhance smart regulation capabilities. As of the end of July 2024, there are 20,152 registered and filed entities for cosmetics nationwide, 3,145 domestic responsible parties for cosmetics, and 5,846 cosmetics manufacturing enterprises. There are 1,791,000 regular cosmetics (including 1,735,000 domestically produced and 56,000 imported) and 28,326 special cosmetics (including 23,775 domestically produced and 4,551 imported).

The administration has established a safety risk consultation mechanism for cosmetics, conducting regular assessments of potential risks in the cosmetics sector, and is developing a monitoring platform for online sales of cosmetics to conduct nationwide monitoring of cosmetics sold online.

https://finance.eastmoney.com/a/202409183184582964.html